Fundraising Fox
CoreMap
Burlington, US · Founded 2016 · Delaware corporation · 4 known investors
Find your way into CoreMap
Sign up to see every warm intro you have to CoreMap
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CoreMap team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CoreMap develops medical technology that lets physicians visualize atrial fibrillation (AF), an irregular heart arrhythmia, to inform better treatment options for patients. It targets cardiac electrophysiology and diagnostics.
Founders & leadership
CoreMap was founded in 2016 by Peter Spector and Sarah Kalil.
SK
Sarah KalilCo-Founder, President & CEOSarah Kalil is co-founder, president, and CEO of CoreMap, which develops medical imaging technology for cardiac electrophysiology. She has background in engineering and law, with prior experience in product development, regulatory approvals, fundraising, and M&A transactions.
Board
AR
Adam RothsteinBoard director
AK
Allen KamerBoard director
Investors · 4
Also in the syndicate · 1
Medtroniclead
Reported raises · per SEC filings
Form D private placements$75.3M disclosed across 6 rounds · 2017–2026
▶$35.5MraisedJun 2026 · 73 investors · Other TechnologyRule 506(b)
▶$35.5MraisedJun 2026 · 73 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sarah KalilExecutive Officer, Director
- Gowri RamanDirector
- Allen KamerDirector
- Adam RothsteinDirector
- Offering amount
- $45M
- Amount sold
- $35.5M
- Minimum investment
- $25K
- Sales commissions
- $500K
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.8MraisedJul 2025 · 19 investors · BiotechnologyRule 506(b)
▶$6.8MraisedJul 2025 · 19 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Allen KamerDirector
- Peter SpectorExecutive Officer, Director
- Adam RothsteinDirector
- Sarah O KalilExecutive Officer, Director
- Offering amount
- $30M
- Amount sold
- $6.8M
- Minimum investment
- $1K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$23.2MraisedFeb 2022 · 26 investors · BiotechnologyRule 506(b)
▶$23.2MraisedFeb 2022 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Allen KamerDirector
- Sarah KalilExecutive Officer, Director
- Peter SpectorDirector
- Adam RothsteinDirector
- Offering amount
- $28M
- Amount sold
- $23.2M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.9MraisedSep 2020 · 18 investors · BiotechnologyRule 506(b)
▶$8.9MraisedSep 2020 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- RONNY GINORDirector
- ALLEN KAMERDirector
- SARAH KALILExecutive Officer, Director
- PETER SPECTORDirector
- Offering amount
- $8.9M
- Amount sold
- $8.9M
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$500KraisedMay 2019 · 3 investors · BiotechnologyRule 506(b)
▶$500KraisedMay 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sarah KalilExecutive Officer, Director
- Peter S SpectorDirector
- William GruberDirector
- Offering amount
- $750K
- Amount sold
- $500K
- Minimum investment
- $25K
- Proceeds to insiders
- $125K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$300KraisedSep 2017 · 3 investors · BiotechnologyRule 506(b)
▶$300KraisedSep 2017 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter SpectorExecutive Officer, Director
- Sarah KalilExecutive Officer
- Offering amount
- $500K
- Amount sold
- $300K
- Minimum investment
- $50K
- Proceeds to insiders
- $100K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
MetaMap enterprise-saasMetaMap is a customer identity verification platform that helps businesses onboard users, reduce fraud, and handle KYC and AML compliance using automated tools drawing on data from 80+ global sources. It offers a library of financial, compliance, and government verification tools with integration via API, SDK, or no-code link, and specializes in coverage for Latin America and Africa.
NearmapNearmap is a property intelligence company that provides aerial imagery, AI-derived risk analytics, and building materials data to insurance underwriters and claims teams for risk assessment and catastrophe response. The company serves property and casualty insurers across the United States and operates globally.
Companies working in the same space as CoreMap.
Frequently asked questions
- What does CoreMap do?
- CoreMap develops medical technology that lets physicians visualize atrial fibrillation (AF), an irregular heart arrhythmia, to inform better treatment options for patients. It targets cardiac electrophysiology and diagnostics.
- Who founded CoreMap?
- CoreMap was founded by Peter Spector, Sarah Kalil in 2016.
- Who are CoreMap's investors?
- CoreMap's investors include at Hula, Dudley Fund, P5 Health Ventures.
- How much funding has CoreMap raised?
- CoreMap has disclosed $75.3M raised across 6 rounds.
- Where is CoreMap headquartered?
- CoreMap is headquartered in Burlington, US.